Skip to main content
Erschienen in: International Urology and Nephrology 9/2014

01.09.2014 | Urology - Original Paper

FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers

verfasst von: Torsten Gruschwitz, Mieczyslaw Gajda, Astrid Enkelmann, Marc-Oliver Grimm, Heiko Wunderlich, Marcus Horstmann, Kerstin Junker

Erschienen in: International Urology and Nephrology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

To evaluate FISH analysis of washing urine from the upper urinary tract (UUT) in comparison with cytology (Cyt) for the detection of urothelial cancers.

Patients and methods

In 82 patients with symptoms or abnormalities of the UUT sampling of washing urine for FISH and Cyt and a stepwise diagnostic work-up (e.g. retrograde ureteropyelography, ureterorenoscopy and endoscopic biopsy) were performed. In case of endoscopically and/or histologically proven malignancy patients either underwent nephroureterectomy, partial ureterectomy or local treatment. Sensitivity and specificity for FISH and Cyt as well as its combination were determined.

Results

Urothelial cancer of the UUT was detected in 20 patients. Eleven patients underwent nephroureterectomy, six partial ureterectomy and three endoscopic tumour treatment. This revealed nine pTa, three pT1 and seven muscle-invasive tumours. Twelve tumours were classified as low and seven as high-grade tumours. In one patient with a macroscopic unequivocal finding of tumour, endoscopic laser ablation without histologic confirmation was performed. FISH was evaluable in 76 patients and detected 16 tumours with a sensitivity and specificity of 84.2 and 91.1 %, respectively. Cyt was performed in 79 and was evaluable in 78 patients. It detected ten tumours with a sensitivity and specificity of 52.6 and 91.4 %, respectively. Cyt and FISH together detected 19 tumours with (sensitivity 100 % and specificity 83.6 %).

Conclusion

FISH was more sensitive than and equally specific to Cyt in the detection of urothelial cancers of the UUT. Both markers in combination revealed the best sensitivity, making it a possible approach in future settings.
Literatur
1.
Zurück zum Zitat Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J et al (2011) Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol 60(3):484–92 Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J et al (2011) Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol 60(3):484–92
2.
Zurück zum Zitat Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P (2001) Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116(1):79–86PubMedCrossRef Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P (2001) Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116(1):79–86PubMedCrossRef
3.
Zurück zum Zitat Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L et al (2002) Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168(5):1950–1954PubMedCrossRef Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L et al (2002) Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168(5):1950–1954PubMedCrossRef
4.
Zurück zum Zitat Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC et al (2000) A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164(5):1768–1775PubMedCrossRef Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC et al (2000) A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164(5):1768–1775PubMedCrossRef
5.
Zurück zum Zitat Jones JS (2006) DNA-based molecular cytology for bladder cancer surveillance. Urology 67(3 Suppl 1):35–45 (discussion-7)PubMedCrossRef Jones JS (2006) DNA-based molecular cytology for bladder cancer surveillance. Urology 67(3 Suppl 1):35–45 (discussion-7)PubMedCrossRef
6.
Zurück zum Zitat Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL et al (2002) A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 167(5):2001–2006PubMedCrossRef Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL et al (2002) A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 167(5):2001–2006PubMedCrossRef
7.
Zurück zum Zitat Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Rademark C et al (1999) Cytogenetic analysis of upper urinary tract transitional cell carcinomas. Cancer Genet Cytogenet 115(2):123–127PubMedCrossRef Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Rademark C et al (1999) Cytogenetic analysis of upper urinary tract transitional cell carcinomas. Cancer Genet Cytogenet 115(2):123–127PubMedCrossRef
8.
Zurück zum Zitat Nison L, Roupret M, Bozzini G, Ouzzane A, Audenet F, Pignot G et al (2013) The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 31(1):69–76PubMedCrossRef Nison L, Roupret M, Bozzini G, Ouzzane A, Audenet F, Pignot G et al (2013) The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 31(1):69–76PubMedCrossRef
9.
Zurück zum Zitat Huang WT, Li LY, Pang J, Ruan XX, Sun QP, Yang WJ et al (2012) Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Neoplasma 59(4):355–360PubMedCrossRef Huang WT, Li LY, Pang J, Ruan XX, Sun QP, Yang WJ et al (2012) Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Neoplasma 59(4):355–360PubMedCrossRef
10.
Zurück zum Zitat Marin-Aguilera M, Mengual L, Ribal MJ, Burset M, Arce Y, Ars E et al (2007) Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet 173(2):131–135PubMedCrossRef Marin-Aguilera M, Mengual L, Ribal MJ, Burset M, Arce Y, Ars E et al (2007) Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet 173(2):131–135PubMedCrossRef
11.
Zurück zum Zitat Wang J, Wu J, Peng L, Tu P, Li W, Liu L et al (2012) Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH. Acta Cytol 56(5):533–538PubMedCrossRef Wang J, Wu J, Peng L, Tu P, Li W, Liu L et al (2012) Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH. Acta Cytol 56(5):533–538PubMedCrossRef
12.
Zurück zum Zitat Shan Z, Wu P, Zheng S, Tan W, Zhou H, Zuo Y et al (2010) Evaluation of upper urinary tract tumors by FISH in Chinese patients. Cancer Genet Cytogenet 203(2):238–246PubMedCrossRef Shan Z, Wu P, Zheng S, Tan W, Zhou H, Zuo Y et al (2010) Evaluation of upper urinary tract tumors by FISH in Chinese patients. Cancer Genet Cytogenet 203(2):238–246PubMedCrossRef
13.
Zurück zum Zitat Akkad T, Brunner A, Pallwein L, Gozzi C, Bartsch G, Mikuz G et al (2007) Fluorescence in situ hybridization for detecting upper urinary tract tumors—a preliminary report. Urology 70(4):753–757PubMedCrossRef Akkad T, Brunner A, Pallwein L, Gozzi C, Bartsch G, Mikuz G et al (2007) Fluorescence in situ hybridization for detecting upper urinary tract tumors—a preliminary report. Urology 70(4):753–757PubMedCrossRef
14.
Zurück zum Zitat Mian C, Mazzoleni G, Vikoler S, Martini T, Knuchel-Clark R, Zaak D et al (2010) Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours. Eur Urol 58(2):288–292PubMedCrossRef Mian C, Mazzoleni G, Vikoler S, Martini T, Knuchel-Clark R, Zaak D et al (2010) Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours. Eur Urol 58(2):288–292PubMedCrossRef
15.
Zurück zum Zitat Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
16.
Zurück zum Zitat Inc. V. UroVysion Protocols—(Bladder Cancer FISH Assay) 2000 Inc. V. UroVysion Protocols—(Bladder Cancer FISH Assay) 2000
17.
Zurück zum Zitat Kobayashi Y, Saika T, Miyaji Y, Saegusa M, Arata R, Akebi N et al (2012) Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. World J Urol 30(2):271–275PubMedCrossRef Kobayashi Y, Saika T, Miyaji Y, Saegusa M, Arata R, Akebi N et al (2012) Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. World J Urol 30(2):271–275PubMedCrossRef
18.
Zurück zum Zitat Umiker W, Lapides J, Sourenne R (1962) Exfoliative cytology of papillomas and intra-epithelial carcinomas of the urinary bladder. Acta Cytol 6:255–266PubMed Umiker W, Lapides J, Sourenne R (1962) Exfoliative cytology of papillomas and intra-epithelial carcinomas of the urinary bladder. Acta Cytol 6:255–266PubMed
19.
20.
Zurück zum Zitat Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr, Sosa RE (2000) Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 163(1):52–55PubMedCrossRef Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr, Sosa RE (2000) Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 163(1):52–55PubMedCrossRef
21.
Zurück zum Zitat Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61(1):109–118 (discussion 18)PubMedCrossRef Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61(1):109–118 (discussion 18)PubMedCrossRef
22.
Zurück zum Zitat Luo B, Li W, Deng CH, Zheng FF, Sun XZ, Wang DH et al (2009) Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 189(2):93–97PubMedCrossRef Luo B, Li W, Deng CH, Zheng FF, Sun XZ, Wang DH et al (2009) Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 189(2):93–97PubMedCrossRef
23.
Zurück zum Zitat Hajdinjak T (2008) UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol 26(6):646–651PubMedCrossRef Hajdinjak T (2008) UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol 26(6):646–651PubMedCrossRef
24.
Zurück zum Zitat Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS et al (2003) Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169(6):2101–2105PubMedCrossRef Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS et al (2003) Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169(6):2101–2105PubMedCrossRef
Metadaten
Titel
FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers
verfasst von
Torsten Gruschwitz
Mieczyslaw Gajda
Astrid Enkelmann
Marc-Oliver Grimm
Heiko Wunderlich
Marcus Horstmann
Kerstin Junker
Publikationsdatum
01.09.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 9/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0714-1

Weitere Artikel der Ausgabe 9/2014

International Urology and Nephrology 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.